Global Gamma-aminobutyric Acid (GABA) Competitive Landscape Professional Research Report 2025
Description
Research Summary
Gamma-aminobutyric acid, commonly known as GABA, is a neurotransmitter that plays a crucial role in regulating brain activity by inhibiting nerve transmission. It is an amino acid that acts as an inhibitory neurotransmitter in the central nervous system, calming overexcited nerve signals and promoting a state of relaxation. GABA receptors are widely distributed in the brain and are involved in various physiological functions, including anxiety regulation, stress response, and sleep cycles. While GABA is naturally produced in the brain, it is also available as a dietary supplement. Some people use GABA supplements to potentially alleviate stress, anxiety, and promote better sleep, although the effectiveness of such supplements is a subject of ongoing research. GABA＇s role in maintaining the balance between excitation and inhibition in the brain makes it a crucial component in the complex network of neurotransmitters influencing mental well-being.
According to DIResearch's in-depth investigation and research, the global Gamma-aminobutyric Acid (GABA) market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Gamma-aminobutyric Acid (GABA) include Sanofi, Mylan N.V., Teva Pharmaceutical Industries, Novartis, Aytu BioScience, Dr. Reddy’s Laboratories, Endo Pharmaceuticals, Lupin, Johnson & Johnson Services, Sun Pharmaceutical Industries, Lannett, Cipla, Aurobindo Pharma, Zydus Cadila etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Gamma-aminobutyric Acid (GABA). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Gamma-aminobutyric Acid (GABA) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Gamma-aminobutyric Acid (GABA) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Gamma-aminobutyric Acid (GABA) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Gamma-aminobutyric Acid (GABA) Include:
Sanofi
Mylan N.V.
Teva Pharmaceutical Industries
Novartis
Aytu BioScience
Dr. Reddy’s Laboratories
Endo Pharmaceuticals
Lupin
Johnson & Johnson Services
Sun Pharmaceutical Industries
Lannett
Cipla
Aurobindo Pharma
Zydus Cadila
Gamma-aminobutyric Acid (GABA) Product Segment Include:
Oral
Parenteral
Intrathecal
Others
Gamma-aminobutyric Acid (GABA) Product Application Include:
Hospital
Specialty Clinic
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Gamma-aminobutyric Acid (GABA) Capacity and Production Analysis
Chapter 3: Global Gamma-aminobutyric Acid (GABA) Industry PESTEL Analysis
Chapter 4: Global Gamma-aminobutyric Acid (GABA) Industry Porter's Five Forces Analysis
Chapter 5: Global Gamma-aminobutyric Acid (GABA) Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 6: Global Gamma-aminobutyric Acid (GABA) Market Size and Forecast by Type and Application Analysis
Chapter 7: North America Gamma-aminobutyric Acid (GABA) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: Europe Gamma-aminobutyric Acid (GABA) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: China Gamma-aminobutyric Acid (GABA) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: APAC (Excl. China) Gamma-aminobutyric Acid (GABA) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Latin America Gamma-aminobutyric Acid (GABA) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Middle East and Africa Gamma-aminobutyric Acid (GABA) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 13: Global Gamma-aminobutyric Acid (GABA) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 14: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 15: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 16: Research Findings and Conclusion
Chapter 17: Methodology and Data Sources
Gamma-aminobutyric acid, commonly known as GABA, is a neurotransmitter that plays a crucial role in regulating brain activity by inhibiting nerve transmission. It is an amino acid that acts as an inhibitory neurotransmitter in the central nervous system, calming overexcited nerve signals and promoting a state of relaxation. GABA receptors are widely distributed in the brain and are involved in various physiological functions, including anxiety regulation, stress response, and sleep cycles. While GABA is naturally produced in the brain, it is also available as a dietary supplement. Some people use GABA supplements to potentially alleviate stress, anxiety, and promote better sleep, although the effectiveness of such supplements is a subject of ongoing research. GABA＇s role in maintaining the balance between excitation and inhibition in the brain makes it a crucial component in the complex network of neurotransmitters influencing mental well-being.
According to DIResearch's in-depth investigation and research, the global Gamma-aminobutyric Acid (GABA) market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Gamma-aminobutyric Acid (GABA) include Sanofi, Mylan N.V., Teva Pharmaceutical Industries, Novartis, Aytu BioScience, Dr. Reddy’s Laboratories, Endo Pharmaceuticals, Lupin, Johnson & Johnson Services, Sun Pharmaceutical Industries, Lannett, Cipla, Aurobindo Pharma, Zydus Cadila etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Gamma-aminobutyric Acid (GABA). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Gamma-aminobutyric Acid (GABA) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Gamma-aminobutyric Acid (GABA) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Gamma-aminobutyric Acid (GABA) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Gamma-aminobutyric Acid (GABA) Include:
Sanofi
Mylan N.V.
Teva Pharmaceutical Industries
Novartis
Aytu BioScience
Dr. Reddy’s Laboratories
Endo Pharmaceuticals
Lupin
Johnson & Johnson Services
Sun Pharmaceutical Industries
Lannett
Cipla
Aurobindo Pharma
Zydus Cadila
Gamma-aminobutyric Acid (GABA) Product Segment Include:
Oral
Parenteral
Intrathecal
Others
Gamma-aminobutyric Acid (GABA) Product Application Include:
Hospital
Specialty Clinic
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Gamma-aminobutyric Acid (GABA) Capacity and Production Analysis
Chapter 3: Global Gamma-aminobutyric Acid (GABA) Industry PESTEL Analysis
Chapter 4: Global Gamma-aminobutyric Acid (GABA) Industry Porter's Five Forces Analysis
Chapter 5: Global Gamma-aminobutyric Acid (GABA) Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 6: Global Gamma-aminobutyric Acid (GABA) Market Size and Forecast by Type and Application Analysis
Chapter 7: North America Gamma-aminobutyric Acid (GABA) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: Europe Gamma-aminobutyric Acid (GABA) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: China Gamma-aminobutyric Acid (GABA) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: APAC (Excl. China) Gamma-aminobutyric Acid (GABA) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Latin America Gamma-aminobutyric Acid (GABA) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Middle East and Africa Gamma-aminobutyric Acid (GABA) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 13: Global Gamma-aminobutyric Acid (GABA) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 14: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 15: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 16: Research Findings and Conclusion
Chapter 17: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Gamma-aminobutyric Acid (GABA) Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Gamma-aminobutyric Acid (GABA) Product by Type
- 1.2.1 Oral
- 1.2.2 Parenteral
- 1.2.3 Intrathecal
- 1.2.4 Others
- 1.3 Gamma-aminobutyric Acid (GABA) Product by Application
- 1.3.1 Hospital
- 1.3.2 Specialty Clinic
- 1.3.3 Other
- 1.4 Global Gamma-aminobutyric Acid (GABA) Market Revenue and Sales Analysis
- 1.4.1 Global Gamma-aminobutyric Acid (GABA) Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Gamma-aminobutyric Acid (GABA) Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Gamma-aminobutyric Acid (GABA) Market Sales Price Trend Analysis (2020-2032)
- 1.5 Gamma-aminobutyric Acid (GABA) Industry Trends and Innovation
- 1.5.1 Gamma-aminobutyric Acid (GABA) Industry Trends and Innovation
- 1.5.2 Gamma-aminobutyric Acid (GABA) Market Drivers and Challenges
- 2 Global Gamma-aminobutyric Acid (GABA) Capacity and Production Analysis
- 2.1 Global Gamma-aminobutyric Acid (GABA) Capacity, Production and Utilization (2020-2032)
- 2.2 Global Gamma-aminobutyric Acid (GABA) Production Growth Trend by Region: 2024 VS 2025 VS 2030
- 2.3 Global Gamma-aminobutyric Acid (GABA) Production by Region
- 2.3.1 Global Gamma-aminobutyric Acid (GABA) Production by Region (2020-2025)
- 2.3.2 Global Gamma-aminobutyric Acid (GABA) Production Forecast by Region (2026-2032)
- 2.3.3 Global Gamma-aminobutyric Acid (GABA) Production Market Share by Region (2020-2032)
- 3 Gamma-aminobutyric Acid (GABA) Market PESTEL Analysis
- 3.1 Political Factors Analysis
- 3.2 Economic Factors Analysis
- 3.3 Social Factors Analysis
- 3.4 Technological Factors Analysis
- 3.5 Environmental Factors Analysis
- 3.6 Legal Factors Analysis
- 4 Gamma-aminobutyric Acid (GABA) Market Porter's Five Forces Analysis
- 4.1 Competitive Rivalry
- 4.2 Threat of New Entrants
- 4.3 Bargaining Power of Suppliers
- 4.4 Bargaining Power of Buyers
- 4.5 Threat of Substitutes
- 5 Global Gamma-aminobutyric Acid (GABA) Market Analysis by Regions
- 5.1 Gamma-aminobutyric Acid (GABA) Overall Market: 2024 VS 2025 VS 2032
- 5.2 Global Gamma-aminobutyric Acid (GABA) Revenue and Forecast Analysis (2020-2032)
- 5.2.1 Global Gamma-aminobutyric Acid (GABA) Revenue and Market Share by Region (2020-2025)
- 5.2.2 Global Gamma-aminobutyric Acid (GABA) Revenue and Market Forecast by Region (2026-2032)
- 5.3 Global Gamma-aminobutyric Acid (GABA) Sales and Forecast Analysis (2020-2032)
- 5.3.1 Global Gamma-aminobutyric Acid (GABA) Sales and Market Share by Region (2020-2025)
- 5.3.2 Global Gamma-aminobutyric Acid (GABA) Sales and Market Forecast by Region (2026-2032)
- 5.4 Global Gamma-aminobutyric Acid (GABA) Sales Price Trend Analysis (2020-2032)
- 6 Global Gamma-aminobutyric Acid (GABA) Market Size by Type and Application
- 6.1 Global Gamma-aminobutyric Acid (GABA) Market Size by Type
- 6.1.1 Global Gamma-aminobutyric Acid (GABA) Revenue and Forecast Analysis by Type (2020-2032)
- 6.1.2 Global Gamma-aminobutyric Acid (GABA) Sales and Forecast Analysis by Type (2020-2032)
- 6.2 Global Gamma-aminobutyric Acid (GABA) Market Size by Application
- 6.2.1 Global Gamma-aminobutyric Acid (GABA) Revenue and Forecast Analysis by Application (2020-2032)
- 6.2.2 Global Gamma-aminobutyric Acid (GABA) Sales and Forecast Analysis by Application (2020-2032)
- 7 North America
- 7.1 North America Gamma-aminobutyric Acid (GABA) Market Size and Growth Rate Analysis (2020-2032)
- 7.2 North America Key Manufacturers Analysis
- 7.3 North America Gamma-aminobutyric Acid (GABA) Market Size by Type
- 7.3.1 North America Gamma-aminobutyric Acid (GABA) Sales by Type (2020-2032)
- 7.3.2 North America Gamma-aminobutyric Acid (GABA) Revenue by Type (2020-2032)
- 7.4 North America Gamma-aminobutyric Acid (GABA) Market Size by Application
- 7.4.1 North America Gamma-aminobutyric Acid (GABA) Sales by Application (2020-2032)
- 7.4.2 North America Gamma-aminobutyric Acid (GABA) Revenue by Application (2020-2032)
- 7.5 North America Gamma-aminobutyric Acid (GABA) Market Size by Country
- 7.5.1 US
- 7.5.2 Canada
- 8 Europe
- 8.1 Europe Gamma-aminobutyric Acid (GABA) Market Size and Growth Rate Analysis (2020-2032)
- 8.2 Europe Key Manufacturers Analysis
- 8.3 Europe Gamma-aminobutyric Acid (GABA) Market Size by Type
- 8.3.1 Europe Gamma-aminobutyric Acid (GABA) Sales by Type (2020-2032)
- 8.3.2 Europe Gamma-aminobutyric Acid (GABA) Revenue by Type (2020-2032)
- 8.4 Europe Gamma-aminobutyric Acid (GABA) Market Size by Application
- 8.4.1 Europe Gamma-aminobutyric Acid (GABA) Sales by Application (2020-2032)
- 8.4.2 Europe Gamma-aminobutyric Acid (GABA) Revenue by Application (2020-2032)
- 8.5 Europe Gamma-aminobutyric Acid (GABA) Market Size by Country
- 8.5.1 Germany
- 8.5.2 France
- 8.5.3 United Kingdom
- 8.5.4 Italy
- 8.5.5 Spain
- 8.5.6 Benelux
- 9 China
- 9.1 China Gamma-aminobutyric Acid (GABA) Market Size and Growth Rate Analysis (2020-2032)
- 9.2 China Key Manufacturers Analysis
- 9.3 China Gamma-aminobutyric Acid (GABA) Market Size by Type
- 9.3.1 China Gamma-aminobutyric Acid (GABA) Sales by Type (2020-2032)
- 9.3.2 China Gamma-aminobutyric Acid (GABA) Revenue by Type (2020-2032)
- 9.4 China Gamma-aminobutyric Acid (GABA) Market Size by Application
- 9.4.1 China Gamma-aminobutyric Acid (GABA) Sales by Application (2020-2032)
- 9.4.2 China Gamma-aminobutyric Acid (GABA) Revenue by Application (2020-2032)
- 10 APAC (excl. China)
- 10.1 APAC (excl. China) Gamma-aminobutyric Acid (GABA) Market Size and Growth Rate Analysis (2020-2032)
- 10.2 APAC (excl. China) Key Manufacturers Analysis
- 10.3 APAC (excl. China) Gamma-aminobutyric Acid (GABA) Market Size by Type
- 10.3.1 APAC (excl. China) Gamma-aminobutyric Acid (GABA) Sales by Type (2020-2032)
- 10.3.2 APAC (excl. China) Gamma-aminobutyric Acid (GABA) Revenue by Type (2020-2032)
- 10.4 APAC (excl. China) Gamma-aminobutyric Acid (GABA) Market Size by Application
- 10.4.1 APAC (excl. China) Gamma-aminobutyric Acid (GABA) Sales by Application (2020-2032)
- 10.4.2 APAC (excl. China) Gamma-aminobutyric Acid (GABA) Revenue by Application (2020-2032)
- 10.5 APAC (excl. China) Gamma-aminobutyric Acid (GABA) Market Size by Country
- 10.5.1 Japan
- 10.5.2 South Korea
- 10.5.3 India
- 10.5.4 Australia
- 10.5.5 Southeast Asia
- 11 Latin America
- 11.1 Latin America Gamma-aminobutyric Acid (GABA) Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Latin America Key Manufacturers Analysis
- 1`.3 Latin America Gamma-aminobutyric Acid (GABA) Market Size by Type
- 11.3.1 Latin America Gamma-aminobutyric Acid (GABA) Sales by Type (2020-2032)
- 11.3.2 Latin America Gamma-aminobutyric Acid (GABA) Revenue by Type (2020-2032)
- 11.4 Latin America Gamma-aminobutyric Acid (GABA) Market Size by Application
- 11.4.1 Latin America Gamma-aminobutyric Acid (GABA) Sales by Application (2020-2032)
- 11.4.2 Latin America Gamma-aminobutyric Acid (GABA) Revenue by Application (2020-2032)
- 11.5 Latin America Gamma-aminobutyric Acid (GABA) Market Size by Country
- 11.6 Latin America Gamma-aminobutyric Acid (GABA) Market Size by Country
- 11.6.1 Mexico
- 11.6.2 Brazil
- 12 Middle East & Africa
- 12.1 Middle East & Africa Gamma-aminobutyric Acid (GABA) Market Size and Growth Rate Analysis (2020-2032)
- 12.2 Middle East & Africa Key Manufacturers Analysis
- 12.3 Middle East & Africa Gamma-aminobutyric Acid (GABA) Market Size by Type
- 12.3.1 Middle East & Africa Gamma-aminobutyric Acid (GABA) Sales by Type (2020-2032)
- 12.3.2 Middle East & Africa Gamma-aminobutyric Acid (GABA) Revenue by Type (2020-2032)
- 12.4 Middle East & Africa Gamma-aminobutyric Acid (GABA) Market Size by Application
- 12.4.1 Middle East & Africa Gamma-aminobutyric Acid (GABA) Sales by Application (2020-2032)
- 12.4.2 Middle East & Africa Gamma-aminobutyric Acid (GABA) Revenue by Application (2020-2032)
- 12.5 Middle East Gamma-aminobutyric Acid (GABA) Market Size by Country
- 12.5.1 Saudi Arabia
- 12.5.2 South Africa
- 13 Competition by Manufacturers
- 13.1 Global Gamma-aminobutyric Acid (GABA) Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 13.1.1 Global Gamma-aminobutyric Acid (GABA) Market Sales by Key Manufacturers (2021-2025)
- 13.1.2 Global Gamma-aminobutyric Acid (GABA) Market Revenue by Key Manufacturers (2021-2025)
- 13.1.3 Global Gamma-aminobutyric Acid (GABA) Average Sales Price by Manufacturers (2021-2025)
- 13.2 Gamma-aminobutyric Acid (GABA) Competitive Landscape Analysis and Market Dynamic
- 13.2.1 Gamma-aminobutyric Acid (GABA) Competitive Landscape Analysis
- 13.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 13.2.3 Market Dynamic
- 14 Key Companies Analysis
- 14.1 Sanofi
- 14.1.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.1.2 Sanofi Gamma-aminobutyric Acid (GABA) Product Portfolio
- 14.1.3 Sanofi Gamma-aminobutyric Acid (GABA) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.2 Mylan N.V.
- 14.2.1 Mylan N.V. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.2.2 Mylan N.V. Gamma-aminobutyric Acid (GABA) Product Portfolio
- 14.2.3 Mylan N.V. Gamma-aminobutyric Acid (GABA) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.3 Teva Pharmaceutical Industries
- 14.3.1 Teva Pharmaceutical Industries Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.3.2 Teva Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Product Portfolio
- 14.3.3 Teva Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.4 Novartis
- 14.4.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.4.2 Novartis Gamma-aminobutyric Acid (GABA) Product Portfolio
- 14.4.3 Novartis Gamma-aminobutyric Acid (GABA) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.5 Aytu BioScience
- 14.5.1 Aytu BioScience Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.5.2 Aytu BioScience Gamma-aminobutyric Acid (GABA) Product Portfolio
- 14.5.3 Aytu BioScience Gamma-aminobutyric Acid (GABA) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.6 Dr. Reddy’s Laboratories
- 14.6.1 Dr. Reddy’s Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.6.2 Dr. Reddy’s Laboratories Gamma-aminobutyric Acid (GABA) Product Portfolio
- 14.6.3 Dr. Reddy’s Laboratories Gamma-aminobutyric Acid (GABA) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.7 Endo Pharmaceuticals
- 14.7.1 Endo Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.7.2 Endo Pharmaceuticals Gamma-aminobutyric Acid (GABA) Product Portfolio
- 14.7.3 Endo Pharmaceuticals Gamma-aminobutyric Acid (GABA) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.8 Lupin
- 14.8.1 Lupin Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.8.2 Lupin Gamma-aminobutyric Acid (GABA) Product Portfolio
- 14.8.3 Lupin Gamma-aminobutyric Acid (GABA) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.9 Johnson & Johnson Services
- 14.9.1 Johnson & Johnson Services Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.9.2 Johnson & Johnson Services Gamma-aminobutyric Acid (GABA) Product Portfolio
- 14.9.3 Johnson & Johnson Services Gamma-aminobutyric Acid (GABA) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.10 Sun Pharmaceutical Industries
- 14.10.1 Sun Pharmaceutical Industries Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.10.2 Sun Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Product Portfolio
- 14.10.3 Sun Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.11 Lannett
- 14.11.1 Lannett Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.11.2 Lannett Gamma-aminobutyric Acid (GABA) Product Portfolio
- 14.11.3 Lannett Gamma-aminobutyric Acid (GABA) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.12 Cipla
- 14.12.1 Cipla Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.12.2 Cipla Gamma-aminobutyric Acid (GABA) Product Portfolio
- 14.12.3 Cipla Gamma-aminobutyric Acid (GABA) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.13 Aurobindo Pharma
- 14.13.1 Aurobindo Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.13.2 Aurobindo Pharma Gamma-aminobutyric Acid (GABA) Product Portfolio
- 14.13.3 Aurobindo Pharma Gamma-aminobutyric Acid (GABA) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.14 Zydus Cadila
- 14.14.1 Zydus Cadila Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.14.2 Zydus Cadila Gamma-aminobutyric Acid (GABA) Product Portfolio
- 14.14.3 Zydus Cadila Gamma-aminobutyric Acid (GABA) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 15 Industry Chain Analysis
- 15.1 Gamma-aminobutyric Acid (GABA) Industry Chain Analysis
- 15.2 Gamma-aminobutyric Acid (GABA) Industry Raw Material and Suppliers Analysis
- 15.2.1 Gamma-aminobutyric Acid (GABA) Key Raw Material Supply Analysis
- 15.2.2 Raw Material Suppliers and Contact Information
- 15.3 Gamma-aminobutyric Acid (GABA) Typical Downstream Customers
- 15.4 Gamma-aminobutyric Acid (GABA) Sales Channel Analysis
- 16 Research Findings and Conclusion
- 17 Methodology and Data Source
- 17.1 Methodology/Research Approach
- 17.2 Research Scope
- 17.3 Benchmarks and Assumptions
- 17.4 Date Source
- 17.4.1 Primary Sources
- 17.4.2 Secondary Sources
- 17.5 Data Cross Validation
- 17.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
